Skip to main content
Muzaffar Qazilbash, MD, Oncology, Houston, TX, University of Texas M.D. Anderson Cancer Center

MuzaffarH.QazilbashMD

Oncology Houston, TX

Hematologic Oncology

Professor of Medicine

Dr. Qazilbash is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Qazilbash's full profile

Already have an account?

Education & Training

  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Hematology and Medical Oncology, 1992 - 1995
  • University of Connecticut School of Medicine
    University of Connecticut School of MedicineResidency, Internal Medicine, 1991 - 1992
  • Wright State University Boonshoft School of Medicine
    Wright State University Boonshoft School of MedicineResidency, Internal Medicine, 1989 - 1991
  • Dow University of Health Sciences
    Dow University of Health SciencesClass of 1987

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • OK State Medical License
    OK State Medical License 2020 - 2021
  • TX State Medical License
    TX State Medical License 2002 - 2024
  • WV State Medical License
    WV State Medical License 1999 - 2003
  • VA State Medical License
    VA State Medical License 1994 - 2000
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
    Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
  • Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...  
    Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature

Abstracts/Posters

  • Breaking the Glass Ceiling of Age in Transplant in Multiple Myeloma
    Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression
    Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial
    Muzaffar H. Qazilbash, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Authored Content

  • ASH 2020: What’s New in Stem Cell Transplant and Cellular Therapy in Multiple Myeloma?December 2020

Press Mentions

  • Multiple Myeloma Survivor Finds Success with Stem Cell Transplants
    Multiple Myeloma Survivor Finds Success with Stem Cell TransplantsJanuary 10th, 2017
  • Multiple Myeloma Survivor: Staying Positive Is a Way to Give Back to Others
    Multiple Myeloma Survivor: Staying Positive Is a Way to Give Back to OthersMay 30th, 2020
  • Immunotherapies Target Multiple Myeloma
    Immunotherapies Target Multiple MyelomaNovember 26th, 2020

Professional Memberships

Other Languages

  • Hindi, Urdu

Hospital Affiliations